Union Minister for Chemicals and Fertilizers Shri Sadananda Gowda held a meeting today with senior officials Department of Pharmaceuticals to review the availability of medicines being used in the management of COVID19. In a tweet shared by the Minister he said that Department of Pharmaceuticals is working closely with the States to ensure uninterrupted availability of medicines across the country.… Continue reading "Shri Sadananda Gowda reviews availability of Covid related medicines"
Department of Pharmaceuticals intensified monitoring of availability, production and supply of drugs used for Covid-19 Treatment in early April, 2021 as number of cases of Covid-19 started increasing steeply. Remdesivir is a patented drug, manufactured in India under voluntary licenses granted by Gilead Life Sciences USA, the patent holder, to 7 Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab., Hetero, Jubilant… Continue reading "Substantial increase in number of manufacturing sites of Remdesivir"
Allocation of Remdesivir made upto 23rd May 2021 to ensure its adequate availability across the country- Shri D.V Sadananda Gowda
Considering the requirement of Remdesivir in every state and ensuring its adequate availability, Union Minister of Chemicals & Fertilisers Shri D.V Sadananda Gowda today announced the allocation of Remdesivir made upto 23rd May 2021. Substantial increase has been made in overall production and allocation of Remdesivir , he added. In a letter written to all States by Department of Pharmaceuticals and… Continue reading "Allocation of Remdesivir made upto 23rd May 2021 to ensure its adequate availability across the country- Shri D.V Sadananda Gowda"